Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartsmann

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of teniposide in patients with AIDS-related Kaposi's sarcomaG Schwartsmann, E Sprinz, M Kronfeld, et al.
Biochemical Pharmacology|September 1, 1988
DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effectsG Schwartsmann, G J Peters, E Laurensse, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1988
Pharmacokinetics of Brequinar sodium (NSC 368390; DUP 785) in cerebrospinal fluidG Schwartsmann, W J van der Vijgh, I Klein, et al.
Leukemia|March 1, 1997
Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observationsG Schwartsmann, M S Fernandes, M D Schaan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapyG Schwartsmann, E Sprinz, M Kromfield, et al.
Breast (Edinburgh, Scotland)|December 1, 2009
Breast cancer in Latin America: experts perceptions compared with medical care standardsE Cazap, A Buzaid, C Garbino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials GroupG Schwartsmann, F Medina de Cunha, L A Silveira, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Screening for antiproliferative activity of six southern Brazilian species of HypericumA Ferraz, D H Faria, M N Benneti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Carcinomatous meningitis as a clinical manifestation of pancreatic carcinomaA F Ferreira Filho, F Cardoso, A Di Leo, et al.
Investigational New Drugs|June 1, 2000
A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancerG Schwartsmann, H Schunemann, C N Gorini, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of teniposide in patients with AIDS-related Kaposi's sarcomaG Schwartsmann, E Sprinz, M Kronfeld, et al.
Biochemical Pharmacology|September 1, 1988
DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effectsG Schwartsmann, G J Peters, E Laurensse, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1988
Pharmacokinetics of Brequinar sodium (NSC 368390; DUP 785) in cerebrospinal fluidG Schwartsmann, W J van der Vijgh, I Klein, et al.
Leukemia|March 1, 1997
Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observationsG Schwartsmann, M S Fernandes, M D Schaan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapyG Schwartsmann, E Sprinz, M Kromfield, et al.
Breast (Edinburgh, Scotland)|December 1, 2009
Breast cancer in Latin America: experts perceptions compared with medical care standardsE Cazap, A Buzaid, C Garbino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials GroupG Schwartsmann, F Medina de Cunha, L A Silveira, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Screening for antiproliferative activity of six southern Brazilian species of HypericumA Ferraz, D H Faria, M N Benneti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Carcinomatous meningitis as a clinical manifestation of pancreatic carcinomaA F Ferreira Filho, F Cardoso, A Di Leo, et al.
Investigational New Drugs|June 1, 2000
A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancerG Schwartsmann, H Schunemann, C N Gorini, et al.
Pageof 9